Futura Medical — TickStock

Timeline

Futura Medical signs new US distribution deal with MPG

07:51, 29 Jun 2026

More in Telecoms

BT and Verizon combine international units in $4bn joint venture

BT Group and Verizon have agreed to merge their international enterprise operations into a 50:50 joint venture targeting multinational connectivity, with Verizon paying BT a $625 million equalisation payment.

07:24, 29 Jun 2026

AIM & Small Cap

Tech Today: Cirata raises £6.3m in placing and subscription, Defence Holdings, Zegona Communications

17:04, 26 Jun 2026

Telecoms

Zegona cuts annual interest bill by €60m with €3.7bn refinancing

07:38, 26 Jun 2026

Telecoms

BATM Wins First US Broadband Contract Worth $500k

07:37, 25 Jun 2026

Pharma

Hutchmed's fanregratinib hits 42.5% response rate in bile duct cancer trial

07:33, 25 Jun 2026

Telecoms

Esyasoft given until 21 July to decide on CyanConnode takeover bid

07:35, 24 Jun 2026

Software & SaaS

Market Brief: FirstCash launches recommended takeover of Ramsdens, Tiger Alpha reverse takeover, Severfield, Telecom Plus, Filtronic

08:52, 23 Jun 2026

Aerospace & Defence

Filtronic wins new mmWave contract and guides as it tweaks profit forecast higher

07:20, 23 Jun 2026

Pharma

Beximco Pharma delivers first doses of generic cystic fibrosis treatment at 96% discount to US price

12:32, 22 Jun 2026

Biotech

Sareum publishes Phase 1 data on SDC-1801 in peer-reviewed journal

12:31, 22 Jun 2026

Biotech

Small Caps Today: Kazera Global seals $10.5m Aftan settlement, Maintel, Proteome Sciences, BATM Advanced Communications, Ondine Biomedical

12:11, 22 Jun 2026

Futura Medical is a UK-based pharmaceutical company specializing in the development and commercialization of topical sexual health products, with its lead product Eroxon, a fast-acting over-the-counter treatment for erectile dysfunction approved in over 15 countries including the US and Europe. The company operates through a partnership-driven commercialization model, leveraging consumer healthcare partners for market distribution while maintaining a pipeline that includes Eroxon Intense and WSD4000 for female sexual dysfunction. Listed on the AIM market, Futura Medical focuses on proprietary gel formulations for the OTC sexual health market.

Sector: Telecoms
Market: AIM

Identifiers

Ticker: AIM:FUM
Market: AIM
ISIN: GB0033278473
LEI: 21380053QLT46UNV2303

Learn more on:

GLEIF Companies House

Timeline

Futura Medical signs new US distribution deal with MPG

More in Telecoms

BT and Verizon combine international units in $4bn joint venture

Tech Today: Cirata raises £6.3m in placing and subscription, Defence Holdings, Zegona Communications

Zegona cuts annual interest bill by €60m with €3.7bn refinancing

BATM Wins First US Broadband Contract Worth $500k

Hutchmed's fanregratinib hits 42.5% response rate in bile duct cancer trial

Esyasoft given until 21 July to decide on CyanConnode takeover bid

Market Brief: FirstCash launches recommended takeover of Ramsdens, Tiger Alpha reverse takeover, Severfield, Telecom Plus, Filtronic

Filtronic wins new mmWave contract and guides as it tweaks profit forecast higher

Beximco Pharma delivers first doses of generic cystic fibrosis treatment at 96% discount to US price

Sareum publishes Phase 1 data on SDC-1801 in peer-reviewed journal

Small Caps Today: Kazera Global seals $10.5m Aftan settlement, Maintel, Proteome Sciences, BATM Advanced Communications, Ondine Biomedical

Browse by Sector

Market reports

Energy & Resources

Financials

Technology

Healthcare

Industrials

Consumer